Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 50 of 329 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
![]() |
Company BD Technologies and Innovation (RTP) | Activity: Research and Development | Company Description BD is a global medical technology company working to improve medical discovery, diagnostics and the delivery of care. The RTP site, established in 1972, is the North American hub of BD's global enterprise R&D network. | Location Research Triangle Park |
![]() |
Company Propella Therapeutics Inc. | Activity: Research and Development | Company Description Propella Therapeutics has developed a platform which combines lymphatic targeting with a medicinal chemistry optimization process to create therapeutics for cancer. The lead asset is PRL-02 (abiraterone decanoate) for prostate cancer. | Location Pittsboro |
Company Accord Healthcare Inc. | Activity: Sales and Operations | Company Description Accord Healthcare is the marketing subsidiary of Intas Pharmaceuticals, an India-based company that focuses on manufacturing generic pharmaceuticals and biosimilars for the global market. | Location Durham | |
Company AccuNovo Biotechnologies Inc. | Activity: Research and Development | Company Description Accunovo is developing novel targeted PET imaging probes through a combination of unique biomarker-binding molecules and imaging-guided precision radiopharmaceuticals for solid tumors. | Location Chapel Hill | |
Company Achelios Therapeutics Inc. | Activity: Research and Development | Company Description Achelios Therapeutics develops novel topical therapies for inflammatory pain, such as joint, muscle temporomandibular and migraine pain. | Location Durham | |
Company Adroit Pharmaceutical Development LLC | Activity: Contract Research and Testing | Company Description Adroit Pharmaceutical Development identifies new and improved formulations and process technologies. Its primary focus is on inhalation and dermatological product development. | Location Durham | |
Company AegisCN LLC | Activity: Research and Development | Company Description AegisCN develops technologies and treatments targeting neurological diseases and inflammation. | Location Durham | |
Company Aer Therapeutics | Activity: Research and Development | Company Description Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung diseases with excess mucus and mucus plugs. | Location Raleigh | |
Company Aerami Therapeutics | Activity: Research and Development | Company Description Aerami is developing therapies to address the unmet medical needs of people with serious and rare forms of pulmonary hypertension, including pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. | Location Durham | |
Company Aestas Pharma Inc. | Activity: Research and Development | Company Description Aestas Pharma develops novel diagnostic imaging and disease-modifying therapeutic agents to enable the detection, early treatment and reversal of Alzheimer’s disease when clinical signs are not yet pronounced. | Location Durham | |
Company AimMax Therapeutics Inc. | Activity: Research and Development | Company Description AimMax Therapeutics researches and develops biopharmaceuticals for the treatment of infection, inflammation and pain through in-licensing or co-development with strategic partners. | Location Durham | |
Company Aktis Oncology | Activity: Research and Development | Company Description Aktis Oncology is developing targeted radiopharmaceuticals to treat solid tumor cancers. | Location Durham | |
Company Alcami Corporation (Durham) | Activity: Contract Research and Testing | Company Description Alcami provides contract drug and biologics development and manufacturing services, including formulation development, analytical chemistry, API, solid dose and parenteral drug manufacturing for clinical and commercial markets. Alcami's HQ is in Durham. | Location Durham | |
Company Alcami Corporation (Wilmington) | Activity: Production and Manufacturing | Company Description Alcami provides contract drug and biologics development and manufacturing services, including analytical development, clinical to commercial sterile and oral solid manufacturing, packaging, microbiology, cGMP biostorage, environmental monitoring, and pharmaceutical support services. | Location Wilmington | |
Company Alcon Research LLC | Activity: Research and Development | Company Description Alcon discovers, develops and commercializes first-in-class therapies for the treatment of patients with glaucoma, dry eye, retinal diseases and other diseases of the eye. | Location Durham | |
Company AlphaVax Inc. | Activity: Research and Development | Company Description AlphaVax develops vaccine technology with applications in infectious disease, cancer and biodefense threats. | Location Research Triangle Park | |
Company Amalgent Therapeutics Inc. | Activity: Research and Development | Company Description Amalgent is a clinical-stage company developing novel pain management therapeutics for the treatment of pain without addiction. | Location Greenville | |
Company Amgen | Activity: Production and Manufacturing | Company Description Amgen will manufacture therapeutics for cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation. The site is expected to be operational by 2025. | Location Apex | |
Company AMO Pharma Ltd. | Activity: Research and Development | Company Description AMO Pharma is developing new treatments for serious and debilitating diseases including rare genetic disorders. | Location Durham | |
Company Aniluxx Biotechnology Inc. | Activity: Research and Development | Company Description Aniluxx Biotechnology translates human therapies to dogs, cats and horses to treat itching and pain. | Location Chapel Hill | |
Company APIE Therapeutics Inc. | Activity: Research and Development | Company Description APIE Therapeutics is developing therapies for fibrosis and related diseases. Its biology platform is the activation of the Apelinergic System signaling pathway via Apelin/APJ receptors agonist drug therapies. | Location Research Triangle Park | |
Company Archerfish Co. | Activity: Research and Development | Company Description
Archerfish develops small molecule drugs to reduce tissue fibrosis and corneal scarring. |
Location Cary | |
Company Ardeal Pharma Inc. | Activity: Research and Development | Company Description Ardeal Pharma is a virtual pharma company developing patented stabilized sulforaphane for the dermal pharmaceutical and cosmetic markets. | Location Brevard | |
Company Ardeal Research Institute | Activity: Research and Development | Company Description Ardeal Research Institute is a non-profit organization that develops drug discovery capabilities of the natural resources in Western North Carolina. The Institute has collaboration agreements in place with Brevard College and the N.C. Arboretum. | Location Brevard | |
Company Areteia Therapeutics Inc. | Activity: Research and Development | Company Description Areteia Therapeutics is developing the first oral drug for eosinophilic asthma. | Location Chapel Hill | |
Company Arrivo BioVentures LLC | Activity: Research and Development | Company Description Arrivo BioVentures accelerates biologics and small molecules from IND readiness through a clinical proof of concept, with biologics in development for dermatologic conditions. | Location Morrisville | |
Company Asinex | Activity: Contract Research and Testing | Company Description Asinex designs small-molecule libraries and provides lead optimization, custom synthesis and other chemistry services. The Winston-Salem location is the company's U.S. headquarters. | Location Winston-Salem | |
Company AskBio | Activity: Research and Development | Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. | Location Research Triangle Park | |
Company Astellas Gene Therapies | Activity: Production and Manufacturing | Company Description Astellas Gene Therapies manufactures AAV gene therapy products for rare diseases. | Location Sanford | |
Company AstraZeneca (Durham-Winchester) | Activity: Research and Development | Company Description AstraZeneca's Winchester Place site in Durham specializes in research and development across the biopharmaceuticals, vaccines and immune therapies, rare disease and oncology business units. | Location Durham | |
Company Asymchem Inc. | Activity: Sales and Operations | Company Description Asymchem offers CMC and CDMO services, focused on developing processes for late-phase to commercial APIs and HPAPIs, and small-molecule manufacturing and development. Asymchem is USFDA- and TGA-inspected. | Location Morrisville | |
Company Atsena Therapeutics Inc. | Activity: Research and Development | Company Description Atsena Therapeutics is developing ocular gene therapies to reverse or prevent blindness. | Location Durham | |
Company Auration Biotech Inc. | Activity: Research and Development | Company Description Auration Biotech is developing novel therapeutics for ear, nose and throat diseases. | Location Chapel Hill | |
Company Aurobindo Pharma USA Inc. | Activity: Research and Development | Company Description Aurobindo Pharma is a generic drug manufacturer. Aurobindo develops inhalation and dermatological products from the company's U.S. research and development headquarters in North Carolina. | Location Durham | |
Company Avior Inc. | Activity: Research and Development | Company Description Avior is a clinical-stage pharmaceutical company developing treatments for patients suffering from chronic liver disease (CLD) associated pruritus and pruritus in atopic dermatitis. | Location Cary | |
Company Balanced Pharma Inc. | Activity: Research and Development | Company Description Balanced Pharma is developing pH-balanced (buffered) injectable anesthetic drugs with enhanced usability qualities for use in dental and dermatological surgery. | Location Cornelius | |
Company Ballek Biologics LLC | Activity: Research and Development | Company Description Ballek Biologics is developing a therapeutic to reverse opioid overdose. | Location Raleigh | |
Company Banner Life Sciences LLC | Activity: Research and Development | Company Description Banner Life Sciences develops formulation technologies (gelcaps, tablets and sterile injectables) and licenses and markets prescription, over-the-counter and nutritional products. | Location High Point | |
Company Bantam Pharmaceutical LLC | Activity: Research and Development | Company Description Bantam Pharmaceutical develops small molecule cancer therapeutics for hematological malignancies and select solid tumors. | Location Durham | |
Company Base4 Biotechnology Inc. | Activity: Research and Development | Company Description Base4 is developing a biotechnology platform designed to visualize RNA dynamics at the atomic level. The company's platform aids in small molecule drug discovery. | Location Durham | |
Company Basking Biosciences Inc. | Activity: Research and Development | Company Description Basking Biosciences is developing a reversible anti-thrombotic therapeutic to treat ischemic stroke. | Location Research Triangle Park | |
Company Bavarian Nordic Inc. | Activity: Research and Development | Company Description Bavarian Nordic develops, manufactures and commercializes cancer immunotherapies and vaccines for infectious diseases. | Location Durham | |
Company BE Pharmaceuticals USA Inc. | Activity: Sales and Operations | Company Description BE Pharmaceuticals USA is the US office for Biological E Ltd., a vaccine manufacturing company headquartered in India. | Location Cary | |
Company Beam Therapeutics | Activity: Production and Manufacturing | Company Description Beam Therapeutics will manufacture precision genetic medicines through the use of base editing technology at its RTP site. | Location Durham | |
Company Bedrock Therapeutics Inc. | Activity: Research and Development | Company Description Bedrock Therapeutics is an AAV research and development company developing platform technologies and therapeutics. | Location Raleigh | |
Company Belhaven Biopharma Inc. | Activity: Research and Development | Company Description Belhaven Biopharma is developing dry powder nasal products for a variety of indications. | Location Raleigh | |
Company BioAesthetics Corporation | Activity: Research and Development | Company Description BioAesthetics Corporation is developing biomaterials, including the NACgraft, a nipple areolar complex graft to be used in regenerating the nipple-areolar complex for mastectomy patients. | Location Durham | |
Company BioAgilytix Labs LLC | Activity: Contract Research and Testing | Company Description BioAgilytix is a global contract research organization and provides PK, immunogenicity, biomarkers, and cell-based assays supporting the development and release testing of therapeutics across all stages of drug development. | Location Durham | |
Company Biocomposites Inc. | Activity: Sales and Operations | Company Description Biocomposites develops, manufactures and distributes calcium compound devices to regenerate and repair bone and soft tissue for use in musculoskeletal infections, trauma, spine and sports injuries. The Wilmington office is a sales office. | Location Wilmington | |
Company BioCryst Pharmaceuticals Inc. | Activity: Research and Development | Company Description BioCryst Pharmaceuticals designs and develops novel, small-molecule oral drugs that block key enzymes to treat rare diseases. The Durham location houses BioCryst's clinical, regulatory and executive teams. | Location Durham |